SCHEMBL30438781

SCHEMBL30438781

CC1COc2ccc(C=O)cc2O1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.56
TDP1 Q9NUW8 3/20 0.56
HSD17B10 Q99714 1/20 0.56
CYP3A4 P08684 2/20 0.38
ATM Q13315 1/20 0.38
KDM4E B2RXH2 3/20 0.37
HPGD P15428 1/20 0.37
PTGS2 P35354 1/20 0.37
MAPT P10636 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
PIK3CA P42336 1/20 0.35
DYRK1A Q13627 1/20 0.35
DYRK2 Q92630 1/20 0.35
DYRK1B Q9Y463 1/20 0.35
MEN1 O00255 1/20 0.35
LMNA P02545 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25351523 1.00 ALDH1A1 (0.56) ALDH1A1TDP1HSD17B10CYP3A4ATM
SCHEMBL2919434 0.93 ALDH1A1 (0.56) ALDH1A1TDP1HSD17B10CYP3A4ATM
SCHEMBL30715295 0.93 ALDH1A1 (0.56) ALDH1A1TDP1HSD17B10CYP3A4ATM
Bicarbonate SCHEMBL26696522 0.91 ALDH1A1 (0.47) ALDH1A1TDP1HSD17B10CYP3A4KDM4E
SCHEMBL26750495 0.80 ALDH1A1 (0.51) ALDH1A1TDP1HSD17B10MAPTSMN1; SMN2
SCHEMBL10620281 0.78 ALDH1A1 (0.52) ALDH1A1TDP1HSD17B10KDM4EHPGD
SCHEMBL2232812 0.77 ALDH1A1 (0.50) ALDH1A1TDP1HSD17B10KDM4EHPGD
SCHEMBL25351239 0.76 MTNR1A (0.39) ALDH1A1SMN1; SMN2GAA
SCHEMBL31550590 0.76 MTNR1A (0.39) ALDH1A1SMN1; SMN2GAA
SCHEMBL24328879 0.76 ALDH1A1 (0.51) ALDH1A1TDP1HSD17B10HPGDPTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250263417-A1 SUBSTITUTED PYRIMIDO[1,2-B]PYRIDAZINES AS POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 H. LUNDBECK A/S (DK) 2025-08-21 US disclosed
CN-116209446-B 7- (Piperidin-1-yl) -4H-pyrimido [1,2-B ] pyridazin-4-one derivatives as positive allosteric modulators of muscarinic acetylcholine receptor M4 范德堡大学 2025-05-13 CN disclosed
WO-2023227737-A9 HERBICIDAL COMPOUNDS SYNGENTA CROP PROTECTION AG (CH) 2024-03-07 WO disclosed
WO-2023227737-A1 HERBICIDAL COMPOUNDS SYNGENTA CROP PROTECTION AG (CH) 2023-11-30 WO disclosed
CN-116209446-A 7- (piperidin-1-yl) -4H-pyrimido [1,2-B ] pyridazin-4-one derivatives as positive allosteric modulators of muscarinic acetylcholine receptor M4 范德堡大学 2023-06-02 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250263417-A1 SUBSTITUTED PYRIMIDO[1,2-B]PYRIDAZINES AS POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 CHRM2, CHRM5, CHRM3 ALDH1A1 1664/4885TDP1 1416/4885HSD17B10 3640/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.